Neurology
Hopper Health Launches Personalized Primary Care For Neurodivergent Adults
One in five adults experiences neurodivergent conditions like Autism, ADHD, Tourette's, and OCD, and is more likely to avoid care due to previous negativ...
March 17, 2023 | News
"Anura™ contactless health monitoring tech to integrate with mobile devices
Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...
February 27, 2023 | News
Inventia Life Science collaborates with MSD to develop 3D advanced cell models
Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...
February 16, 2023 | News
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...
February 15, 2023 | News
STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option
Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...
February 13, 2023 | News
New Parkinson's Disease treatment added to PBS
Opicapone will be listed for the first time as additional therapy to treat Parkinson’s disease, helping other medications work better and for ...
February 02, 2023 | News
Eppendorf & Science Prize for Neurobiology 2023 Call for Entries!
This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...
February 02, 2023 | News
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China
AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psyc...
January 17, 2023 | News
Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mass...
January 16, 2023 | News
FDA approves LEQEMBI™ (lecanemab-irmb) under the Accelerated Approval pathway for the treatment of Alzheimer's disease
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that under the Accelerated Approval pathway the U.S. Food and Drug...
January 09, 2023 | News
FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial
Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to proceed with ...
December 23, 2022 | News
STADA partners with BIAL to bring Ongentys to Parkinson’s patients in Australia
STADA receives from BIAL exclusive rights to market and distribute Ongentys (opicapone) capsules in Australia STADA Specialty Head Bryan Kim: "Ongentys ...
December 19, 2022 | News
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
Actinogen Medical Limited (ASX: ACW) is pleased to announce that the first patient has been randomized and treated in the XanaCIDD Phase 2 depression ...
December 15, 2022 | News
Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases
Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...
December 15, 2022 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
